- Home
- ORMP vs IMNM Comparison
ORMP vs IMNM Comparison
Compare ORMP & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORMP
- IMNM
- Stock Information
- Founded
- ORMP 2002
- IMNM 2006
- Country
- ORMP United States
- IMNM United States
- Employees
- ORMP N/A
- IMNM N/A
- Industry
- ORMP Biotechnology: Pharmaceutical Preparations
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- ORMP Health Care
- IMNM Health Care
- Exchange
- ORMP Nasdaq
- IMNM Nasdaq
- Market Cap
- ORMP 104.6M
- IMNM 1.2B
- IPO Year
- ORMP N/A
- IMNM 2020
- Fundamental
- Price
- ORMP $2.41
- IMNM $15.59
- Analyst Decision
- ORMP
- IMNM Strong Buy
- Analyst Count
- ORMP 0
- IMNM 9
- Target Price
- ORMP N/A
- IMNM $24.89
- AVG Volume (30 Days)
- ORMP 135.1K
- IMNM 1.4M
- Earning Date
- ORMP 11-07-2025
- IMNM 11-12-2025
- Dividend Yield
- ORMP N/A
- IMNM N/A
- EPS Growth
- ORMP N/A
- IMNM N/A
- EPS
- ORMP N/A
- IMNM N/A
- Revenue
- ORMP $2,000,000.00
- IMNM $12,589,000.00
- Revenue This Year
- ORMP N/A
- IMNM N/A
- Revenue Next Year
- ORMP N/A
- IMNM $85.68
- P/E Ratio
- ORMP N/A
- IMNM N/A
- Revenue Growth
- ORMP N/A
- IMNM 16.74
- 52 Week Low
- ORMP $1.82
- IMNM $5.15
- 52 Week High
- ORMP $3.09
- IMNM $17.32
- Technical
- Relative Strength Index (RSI)
- ORMP 53.15
- IMNM 62.90
- Support Level
- ORMP $2.23
- IMNM $15.35
- Resistance Level
- ORMP $2.45
- IMNM $17.32
- Average True Range (ATR)
- ORMP 0.12
- IMNM 1.14
- MACD
- ORMP -0.01
- IMNM 0.03
- Stochastic Oscillator
- ORMP 64.52
- IMNM 57.60
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.